相似文献
1
Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics.
Am J Obstet Gynecol. 2010 Sep;203(3):254.e1-12. doi: 10.1016/j.ajog.2010.06.029.
2
Maternal Betamethasone for Prevention of Respiratory Distress Syndrome in Neonates: Population Pharmacokinetic and Pharmacodynamic Approach.
Clin Pharmacol Ther. 2020 Nov;108(5):1026-1035. doi: 10.1002/cpt.1887. Epub 2020 Jun 4.
3
The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery.
Am J Obstet Gynecol. 2010 Sep;203(3):219.e1-5. doi: 10.1016/j.ajog.2010.04.047. Epub 2010 Jul 1.
4
Pharmacokinetics of 17 alpha hydroxyprogesterone caproate in singleton pregnancy and its influence of maternal body size measures.
Am J Obstet Gynecol MFM. 2019 Nov;1(4):100051. doi: 10.1016/j.ajogmf.2019.100051. Epub 2019 Sep 30.
5
Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
Am J Obstet Gynecol. 2025 Feb;232(2):228.e1-228.e9. doi: 10.1016/j.ajog.2024.05.012. Epub 2024 May 17.
6
Pharmacokinetics of betamethasone in twin and singleton pregnancy.
Clin Pharmacol Ther. 2002 Jan;71(1):39-45. doi: 10.1067/mcp.2002.120250.
7
Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects.
Clin Ther. 2012 Jan;34(1):214-20. doi: 10.1016/j.clinthera.2011.11.022. Epub 2011 Dec 9.
8
The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy.
Am J Obstet Gynecol. 2018 Sep;219(3):301.e1-301.e16. doi: 10.1016/j.ajog.2018.05.007. Epub 2018 May 11.
9
Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy.
Am J Obstet Gynecol. 2020 Dec;223(6):921.e1-921.e10. doi: 10.1016/j.ajog.2020.05.032. Epub 2020 May 21.
10
Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate.
Am J Obstet Gynecol. 2016 Dec;215(6):775.e1-775.e12. doi: 10.1016/j.ajog.2016.08.017. Epub 2016 Aug 20.
引用本文的文献
1
Pharmacokinetics of betamethasone in pre-eclampsia: An in vivo and ex vivo study.
Br J Clin Pharmacol. 2025 Aug;91(8):2327-2339. doi: 10.1002/bcp.70035. Epub 2025 Mar 13.
2
Single-nucleotide polymorphisms in dizygotic twin ovine fetuses are associated with discordant responses to antenatal steroid therapy.
BMC Med. 2025 Feb 4;23(1):65. doi: 10.1186/s12916-025-03910-9.
3
The role of antenatal corticosteroids in twin pregnancy.
Front Pharmacol. 2023 Feb 2;14:1072578. doi: 10.3389/fphar.2023.1072578. eCollection 2023.
4
The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review.
Pharmaceutics. 2022 Jun 11;14(6):1241. doi: 10.3390/pharmaceutics14061241.
5
Do maternal demographics and prenatal history impact the efficacy of betamethasone therapy for threatened preterm labor?
BMC Pregnancy Childbirth. 2021 Jun 24;21(1):442. doi: 10.1186/s12884-021-03949-5.
6
Glucocorticoids, sodium transport mediators, and respiratory distress syndrome in preterm infants.
Pediatr Res. 2021 Apr;89(5):1253-1260. doi: 10.1038/s41390-020-1061-9. Epub 2020 Jul 14.
7
Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain.
Mol Endocrinol. 2015 May;29(5):658-66. doi: 10.1210/me.2015-1042. Epub 2015 Mar 12.
8
Judicious use of antenatal glucocorticoids: putting the risks into the balance.
Facts Views Vis Obgyn. 2011;3(3):215-20.
9
Hierarchical maturation of innate immune defences in very preterm neonates.
Neonatology. 2014;106(1):1-9. doi: 10.1159/000358550. Epub 2014 Mar 6.
10
Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy.
Clin Pharmacokinet. 2014 Apr;53(4):373-83. doi: 10.1007/s40262-013-0123-0.
本文引用的文献
1
Betamethasone dose and formulation for induced lung maturation in fetal sheep.
Am J Obstet Gynecol. 2009 Dec;201(6):611.e1-7. doi: 10.1016/j.ajog.2009.07.014. Epub 2009 Oct 3.
2
Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth.
Cochrane Database Syst Rev. 2008 Oct 8(4):CD006764. doi: 10.1002/14651858.CD006764.pub2.
3
Dosing in obesity: a simple solution to a big problem.
Clin Pharmacol Ther. 2007 Nov;82(5):505-8. doi: 10.1038/sj.clpt.6100381.
4
Mechanism-based concepts of size and maturity in pharmacokinetics.
Annu Rev Pharmacol Toxicol. 2008;48:303-32. doi: 10.1146/annurev.pharmtox.48.113006.094708.
5
Alterations in drug disposition during pregnancy: implications for drug therapy.
Expert Opin Drug Metab Toxicol. 2007 Aug;3(4):557-71. doi: 10.1517/17425225.3.4.557.
6
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004454. doi: 10.1002/14651858.CD004454.pub2.
7
Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers.
BJOG. 2005 Nov;112(11):1492-9. doi: 10.1111/j.1471-0528.2005.00735.x.
8
Quantification of lean bodyweight.
Clin Pharmacokinet. 2005;44(10):1051-65. doi: 10.2165/00003088-200544100-00004.
9
Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Clin Pharmacokinet. 2005;44(10):989-1008. doi: 10.2165/00003088-200544100-00001.
10
Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use.
Drug Metab Dispos. 2005 Aug;33(8):1124-30. doi: 10.1124/dmd.105.004309. Epub 2005 Apr 28.
Zotero 插件